The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Voltarol Retard 100 mg Film-coated Prolonged Release Tablets

Novartis Ireland LimitedPA0896/034/002

Main Information

Trade NameVoltarol Retard 100 mg Film-coated Prolonged Release Tablets
Active SubstancesDiclofenac sodium
Dosage FormProlonged-release tablet
Licence HolderNovartis Ireland Limited
Licence NumberPA0896/034/002

Group Information

ATC CodeM01AB Acetic acid derivatives and related substances
M01AB05 diclofenac


License statusAuthorised
Licence Issued26/07/1983
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0056-024-024
Interchangeable List DocumentPDF of Interchangeable List
« Back